Ototoxicity clinical trials at UCSF

1 in progress, 0 open to eligible people

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
Sorry, not currently recruiting here
A 10 week trial to assess the ability of Tempol to prevent and/or reduce toxicities associated with cisplatin and radiation treatment in head and neck cancer patients. Over the course of the 10 week trial, mucositis, nephrotoxicity, and ototoxicity will be monitored and assessed.
San Francisco, California and other locations

Last updated: November 18, 2024